4//SEC Filing
McKenna Mark C. 4
Accession 0001104659-23-093913
CIK 0001974640other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:06 PM ET
Size
8.2 KB
Accession
0001104659-23-093913
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-17+50,000→ 50,000 totalExercise: $23.60Exp: 2033-08-17→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-17+100,000→ 150,000 totalExercise: $23.60Exp: 2033-08-17→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]This option represents the right to purchase 50,000 shares of the Issuer's common stock, which will vest in thirty-six equal monthly installments over a three-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents the right to purchase 100,000 shares of the Issuer's common stock, which will vest in thirty-six equal monthly installments over a three-year period from the date of grant, contingent upon approval of the option at the Issuer's 2024 Annual Meeting of Stockholders and subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Apogee Therapeutics, Inc.
CIK 0001974640
Entity typeother
Related Parties
1- filerCIK 0001749623
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 4:06 PM ET
- Size
- 8.2 KB